Benzinga | May 10, 2021 04:28PM EDT

Design Therapeutics Q1 EPS $(0.31) Down From $(0.04) YoY

Design Therapeutics (NASDAQ:DSGN) reported quarterly losses of $(0.31) per share. This is a 675 percent decrease over losses of $(0.04) per share from the same period last year.